171 related articles for article (PubMed ID: 30173003)
21. Mapping the world drug problem: science and politics in the United Nations drug control system.
Hallam C; Bewley-Taylor DR
Int J Drug Policy; 2010 Jan; 21(1):1-3. PubMed ID: 19914052
[No Abstract] [Full Text] [Related]
22. Leveraging non-binding instruments for global health governance: reflections from the Global AIDS Reporting Mechanism for WHO reform.
Taylor AL; Alfven T; Hougendobler D; Tanaka S; Buse K
Public Health; 2014 Feb; 128(2):151-60. PubMed ID: 24393497
[TBL] [Abstract][Full Text] [Related]
23. Global Health: A Pivotal Moment Of Opportunity And Peril.
Gostin LO; Friedman EA
Health Aff (Millwood); 2017 Jan; 36(1):159-165. PubMed ID: 28069859
[TBL] [Abstract][Full Text] [Related]
24. International institutions and China's health policy.
Huang Y
J Health Polit Policy Law; 2015 Feb; 40(1):41-71. PubMed ID: 25480846
[TBL] [Abstract][Full Text] [Related]
25. Drug law reform, performativity and the politics of childhood.
Flacks SJ
Int J Drug Policy; 2018 Jan; 51():56-66. PubMed ID: 29202316
[TBL] [Abstract][Full Text] [Related]
26. Human rights in the global response to HIV: findings from the 2008 United Nations General Assembly Special Session Reports.
Gruskin S; Ferguson L; Peersman G; Rugg D
J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S104-10. PubMed ID: 19901622
[TBL] [Abstract][Full Text] [Related]
27. Accountability in the global response to HIV: measuring progress, driving change.
Collins C; Coates TJ; Szekeres G
AIDS; 2008 Aug; 22 Suppl 2(Suppl 2):S105-111. PubMed ID: 18641477
[TBL] [Abstract][Full Text] [Related]
28. Implications of international law for the treatment of cancer: the Single Convention on Narcotic Drugs and the TRIPS Agreement.
Liberman J
Public Health; 2011 Dec; 125(12):840-846. PubMed ID: 22054908
[TBL] [Abstract][Full Text] [Related]
29. Mexico's "ley de narcomenudeo" drug policy reform and the international drug control regime.
Mackey TK; Werb D; Beletsky L; Rangel G; Arredondo J; Strathdee SA
Harm Reduct J; 2014 Nov; 11(1):31. PubMed ID: 25395346
[TBL] [Abstract][Full Text] [Related]
30. Progress in global blood safety for HIV.
Takei T; Amin NA; Schmid G; Dhingra-Kumar N; Rugg D
J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S127-31. PubMed ID: 19901625
[TBL] [Abstract][Full Text] [Related]
31. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
O'Gorman A; Quigley E; Zobel F; Moore K
Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
[TBL] [Abstract][Full Text] [Related]
32. Adding a dedicated public health approach to the international drug control regime.
Tinasti K; Crocket A; Buechli DS
J Public Health Policy; 2015 May; 36(2):248-50. PubMed ID: 25811388
[No Abstract] [Full Text] [Related]
33. UN adopts plans to combat worldwide illicit drug use.
McCarthy M
Lancet; 1998 Jun; 351(9119):1863. PubMed ID: 9652679
[No Abstract] [Full Text] [Related]
34. Drug policy debate is needed.
Gilmore IT
BMJ; 2012 Apr; 344():e2381. PubMed ID: 22474265
[No Abstract] [Full Text] [Related]
35. The politics of drug control in Nigeria: Exclusion, repression and obstacles to policy change.
Klantschnig G
Int J Drug Policy; 2016 Apr; 30():132-9. PubMed ID: 26653206
[TBL] [Abstract][Full Text] [Related]
36. Legitimacy and modernity via policy transfer: the utility of the 2003 Afghan National Drug Control Strategy.
Bewley-Taylor DR
Int J Drug Policy; 2014 Sep; 25(5):1009-18. PubMed ID: 24835270
[TBL] [Abstract][Full Text] [Related]
37. The international dimension of drug policy reform in Uruguay.
von Hoffmann J
Int J Drug Policy; 2016 Aug; 34():27-33. PubMed ID: 27233516
[TBL] [Abstract][Full Text] [Related]
38. UNGASS 2016 on drugs, the first challenge for HIV advocates in the post-2015 era.
Fordham A; Tinasti K
J Int AIDS Soc; 2014; 17(1):19274. PubMed ID: 25053452
[No Abstract] [Full Text] [Related]
39. The future of the international drug control system and national drug prohibitions.
Hall W
Addiction; 2018 Jul; 113(7):1210-1223. PubMed ID: 28884869
[TBL] [Abstract][Full Text] [Related]
40. Global governance and the broader determinants of health: A comparative case study of UNDP's and WTO's engagement with global health.
Gopinathan U; Watts N; Lefebvre A; Cheung A; Hoffman SJ; Røttingen JA
Glob Public Health; 2019 Feb; 14(2):175-189. PubMed ID: 29848178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
